The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Ranked by engagement

Top topics — all time page 6

Ranked by replies, likes and views over all time, with a bonus for topics that reached a marked solution. Engagement is a proxy for usefulness and a poor one; the documentation commons is the better index of what is settled.

1,535 topics · page 6 of 40

TopicParticipantsRepliesViewsActivity
Fixed versus detachable needles: the trade-offs
Posting this under the heading it deserves: Fixed versus detachable needles: the trade-offs Everything below is what sits behind that. I have read the maintained page on this and I still have a gap, so I am…
HNAVPWSMRD+117 121 7.3k 18mo
A well-designed study with a badly written abstract
Posting this under the heading it deserves: A well-designed study with a badly written abstract Everything below is what sits behind that. Comparing SCALE ( N Engl J Med , 2015) with LEADER ( N Engl J Med ,…
RCMICBMRPN+117 128 7.2k 14mo
Follow-up: Individual participant data versus aggregate data
Individual participant data versus aggregate data — setting out what I have, and where I think it stops being reliable. Comparing LEADER ( N Engl J Med , 2016) with SURPASS-4 ( Lancet , 2021) and finding the…
HDAPRSGVRV+101 111 23k 18mo
TB-500 and thymosin beta-4: the fragment versus the protein
TB-500 and thymosin beta-4: the fragment versus the protein Writing it up because I had to work it out twice and would rather nobody else did. I have seen SURPASS-4 ( Lancet , 2021) cited in support of a…
COGDJLDVS+107 118 22k 11mo
Where to report an adverse event officially, by region — a second dataset
On the subject in the title: Where to report an adverse event officially, by region — a second dataset Working notes rather than a conclusion. Asking about a population rather than about a person. The…
JERJNDVFD+108 123 26k 8mo
Citing a preprint in a maintained document: our rule and its reasoning — does this still hold?
The question in the title: Citing a preprint in a maintained document: our rule and its reasoning — does this still hold? I will give what I have already checked below so nobody repeats it. I have seen LEADER…
CRFDSIAST+103 115 24k 10mo
Converting between mg/mL and units per dose, both directions — the long version
Converting between mg/mL and units per dose, both directions — the long version Writing it up because I had to work it out twice and would rather nobody else did. Practical question with the units stated,…
COZAGFSKW+110 132 1.7k 3mo
Can a home kit substitute for a laboratory report? A careful no
Asking directly, because I could not find a straight answer: Can a home kit substitute for a laboratory report? A careful no I would like to understand what this number means before I repeat it anywhere. A…
WMFKNRVNDO+122 131 1.7k 5mo
Why "dose equivalence" between different incretin analogues is a weak concept
Why "dose equivalence" between different incretin analogues is a weak concept I have a specific reason for asking rather than idle curiosity, and the context is below. I have read the maintained page on this…
WVERFYWMB+124 133 11k 5mo
Personal import allowances, compared — a second dataset
Personal import allowances, compared — a second dataset — setting out what I have, and where I think it stops being reliable. A coverage question with the paperwork detail included, since that is what…
CCJHKSAVN+124 132 9.2k 2mo
Journal club: is percentage weight change the right endpoint?
Journal club: is percentage weight change the right endpoint? I have a specific reason for asking rather than idle curiosity, and the context is below. Comparing SURPASS-4 ( Lancet , 2021) with SURMOUNT-OSA (…
IFLEDSSBE+116 120 23k 3mo
Pinch or no pinch, and how needle length changes the answer
Pinch or no pinch, and how needle length changes the answer Writing it up because I had to work it out twice and would rather nobody else did. I have read the maintained page on this and I still have a gap,…
MNNLTIANAD+118 126 11k 9mo
Reference intervals: how they are constructed and why one in twenty flags
Reference intervals: how they are constructed and why one in twenty flags — setting out what I have, and where I think it stops being reliable. General question, not a request for advice about my own care — I…
JMJHKGOTK+104 119 30k 1mo
What is genuinely unknown about long-term amylin agonism
What is genuinely unknown about long-term amylin agonism — that is the question, and I have not found it answered plainly anywhere I have looked. Comparing STEP 8 ( JAMA , 2022) with SURMOUNT-1 ( N Engl J Med…
RMMDSENK+83 91 46k 1d
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ I have a specific reason for asking rather than idle curiosity, and the context is below. Structured report rather than an opinion, following…
PWGEJHKORM+117 130 3.3k 14mo
Second pass at: Adsorptive losses at low concentration, and why dilute solutions are fragile
On the subject in the title: Second pass at: Adsorptive losses at low concentration, and why dilute solutions are fragile Working notes rather than a conclusion. Practical question with the units stated,…
SRMNWFYVS+77 87 58k 4mo
Spreadsheets: an appreciation — what changed since
Spreadsheets: an appreciation — what changed since — setting out what I have, and where I think it stops being reliable. Lower-stakes topic, but the sourcing rule still applies if anyone makes a claim.…
CAFLBSBWD+102 113 26k 17h
Reading a trial's population section before its results
On the subject in the title: Reading a trial's population section before its results Working notes rather than a conclusion. I have seen STEP 2 ( Lancet , 2021) cited in support of a claim I do not think it…
WZOCDJBVK+91 109 22k 2mo
Submitting a sample: the process end to end
On the subject in the title: Submitting a sample: the process end to end Working notes rather than a conclusion. I would like to talk about documentation quality as a signal, separately from product quality.…
DOEVABKPLG+99 114 29k 21h
An ABAB design with a data table and honest limitations — a second dataset
On the subject in the title: An ABAB design with a data table and honest limitations — a second dataset Working notes rather than a conclusion. Session topic: STEP 2 ( Lancet , 2021). Please read it before…
VELIGRAC+106 118 25k 4mo
The "under review" status pill and when a moderator applies it
Posting this under the heading it deserves: The "under review" status pill and when a moderator applies it Everything below is what sits behind that. Session topic: SURMOUNT-4 ( JAMA , 2024). Please read it…
NLAMDOVRV+96 119 17k 3mo
A report I filed that turned out to be wrong, and the correction
A report I filed that turned out to be wrong, and the correction Writing it up because I had to work it out twice and would rather nobody else did. Structured report rather than an opinion, following the…
DOCIAKSGVR+124 132 12k 13mo
Obstructive sleep apnoea and a hard endpoint in this class
On the subject in the title: Obstructive sleep apnoea and a hard endpoint in this class Working notes rather than a conclusion. Asking about a population rather than about a person. The published trials in…
OBFATWAKMS+120 129 1.8k 13mo
Coming back to: An 18-month record including the parts that went badly
Posting this under the heading it deserves: An 18-month record including the parts that went badly Everything below is what sits behind that. Longitudinal report with the method stated, because a number…
SVAKRZACN+83 89 52k 12mo
Stepping down deliberately, and how to do it without losing progress
Stepping down deliberately, and how to do it without losing progress — setting out what I have, and where I think it stops being reliable. Practical question with the units stated, because I have seen how…
EFCCBKEM+98 102 26k 3mo
Identical chromatograms across two different lots
Identical chromatograms across two different lots Writing it up because I had to work it out twice and would rather nobody else did. A logistics question, since the answers here are usually better than…
MACTPFBSO+80 87 58k 18mo
I joined for one answer and stayed for a year — what changed my mind
Posting this under the heading it deserves: I joined for one answer and stayed for a year — what changed my mind Everything below is what sits behind that. Question in the title. Context below, and I have…
KSKVVBBNAV+96 114 17k just now
Official shortage notices and what they authorise
Posting this under the heading it deserves: Official shortage notices and what they authorise Everything below is what sits behind that. Documenting an access outcome, dated, because everything in this…
AVPPNSNGRM+106 119 18k 1mo
Trust level 3 requirements: a clarification — does this still hold?
Asking directly, because I could not find a straight answer: Trust level 3 requirements: a clarification — does this still hold? Process question about how this site works. I have read the guidelines and the…
ASBIABVGR+76 90 57k 9h
Research-use-only labelling: what it means and what it does not
Posting this under the heading it deserves: Research-use-only labelling: what it means and what it does not Everything below is what sits behind that. I would like to talk about documentation quality as a…
ZNPPJENGGR+100 110 37k 5mo